Switching pharmacies?Transfer your prescription to Fairview in 60 seconds.Start your transfer
New patient? Start here500 Katie Avenue, Hattiesburg, MS 39401
601-544-4871Mon to Fri 8am to 6pm | Sat 9am to 1pmAccount
Fairview Pharmacy
Fairview Pharmacy
Patient medication guide

Mounjaro, made simple.

Mounjaro is a tirzepatide medicine prescribed for type 2 diabetes as part of a long-term plan. The rule patients most often miss is that brand, form, strength, and dose schedule are not interchangeable. A Mississippi pharmacist wrote this guide for you.

This guide is here to teach you. It is not medical advice, and it does not replace your doctor or pharmacist. Always do what your doctor tells you, and ask a pharmacist before you change how you take any medicine.

Print this guide for your fridge

The FDA boxed warning, in plain words

  1. Tirzepatide caused thyroid C-cell tumors in animal studies. Because of this, Mounjaro is not for anyone with a personal or family history of medullary thyroid carcinoma, or anyone with a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your doctor before starting if either applies to you.
  2. Tell your doctor right away if you notice a lump in your neck, hoarseness that will not go away, trouble swallowing, or trouble breathing. These can be signs of a thyroid problem.

Your 60 second Mounjaro safety checklist

  • Keep one regular schedule.Use the injection once weekly on the same day, with or without food. Record your product, strength, and weekly day.
  • Increase gradually.Slow dose steps help reduce stomach side effects. Do not speed up an increase or copy another patient's dose.
  • Respond to stomach symptoms.Nausea, vomiting, diarrhea, constipation, and belly pain are common. Use small meals and fluids, and report ongoing or severe symptoms.
  • Prevent low blood sugar.The risk rises when Mounjaro is used with insulin or a sulfonylurea. Review your glucose medicines with your prescriber.
  • Tell the procedure team.Slowed stomach emptying may raise aspiration risk during anesthesia or deep sedation. Tell the team what you use and when you last took it.
  • Know pancreatitis and gallbladder signs.Severe belly pain, especially with vomiting, or upper-right belly pain with fever or yellow skin needs prompt care.

What Mounjaro is and why your doctor gave it to you

Mounjaro is the brand name for tirzepatide. It activates two gut-hormone signals, called the GIP and GLP-1 receptors.

It is FDA approved to improve glucose control in adults with type 2 diabetes. Different patients may receive it for different labeled reasons.

  • Type 2 diabetes. Mounjaro is the tirzepatide brand for type 2 diabetes. Zepbound is a different tirzepatide brand with different labeled uses.

The simple version: Mounjaro uses two meal-response signals to support glucose control, but it must be used in its own labeled form and schedule. It works alongside the rest of your plan, which may include nutrition, activity, glucose monitoring, or other medicines.

How Mounjaro works

Think of Mounjaro as strengthening signals the body normally sends after eating. Its GIP and GLP-1 actions help the pancreas release insulin when glucose is high, reduce excess glucagon, slow stomach emptying, and affect fullness. These actions lower glucose. They are not a substitute for insulin in type 1 diabetes.

The effect builds gradually. Slower stomach emptying explains both some common stomach symptoms and the need to tell an anesthesia team. The medicine does not completely turn hunger or digestion off, and individual results vary.

Your dose

Your strength and schedule depend on your treatment stage, indication, response, side effects, and other medicines. Use the package and prescription currently dispensed to you.

Use Mounjaro once weekly, on the same day, any time, with or without meals. Inject under the skin of the abdomen, thigh, or upper arm and rotate sites. Check that the solution is clear and colorless. Use the Instructions for Use for your exact pen or syringe. Never share a pen, even if the needle is changed.

The labeled escalation starts at 2.5 mg weekly for 4 weeks, then 5 mg. Later increases are in 2.5 mg steps after at least 4 weeks each, if needed.

Do not mix Mounjaro with insulin in the same injection. If both are used, inject them separately and not next to each other. Do not combine Mounjaro with another tirzepatide or GLP-1 medicine unless the prescriber has made a specific transition plan.

Timing, and what to do if you miss a dose

Use Mounjaro once weekly on the same day, any time, with or without meals. Record your weekly day.

If you need to change your weekly day, keep at least 3 days (72 hours) between doses.

If you miss a dose:

  • Take a missed dose within 4 days (96 hours).
  • If more than 4 days have passed, skip it.
  • Keep at least 3 days (72 hours) between doses. Do not double up.
  • If you vomit after an injection, do not repeat it.
  • Call after multiple missed doses. Restarting at a lower step may be safer.

Side effects, what is normal and what is not

Common, especially when starting or increasing the dose:

  • Nausea or early fullness. Eat smaller meals, slow down, and stop when comfortably full.
  • Vomiting or diarrhea. Sip fluids and monitor glucose if you have diabetes.
  • Constipation or belly discomfort. Fluids, movement, and gradual fiber may help. Ask before using a laxative.
  • Injection-site irritation or appetite changes. Rotate sites and protect nutrition.

Call your doctor or pharmacist promptly if you notice:

  • Persistent vomiting or diarrhea, dizziness, very little urine, or other dehydration signs.
  • Upper belly pain, fever, yellow skin or eyes, or clay-colored stools.
  • A neck lump, persistent hoarseness, trouble swallowing, or trouble breathing.
  • New or worsening vision changes, especially with diabetic retinopathy.
  • Repeated low glucose, especially with insulin or a sulfonylurea.
  • Severe constipation, belly swelling, or stomach symptoms that do not go away.

Get urgent help or call 911 if you have:

  • Trouble breathing, swelling of the face, lips, tongue, or throat, fainting, or a rapidly worsening rash.
  • Severe, steady belly pain that may travel to the back, especially with vomiting. This may be pancreatitis.
  • Severe dehydration, confusion, loss of consciousness, or inability to keep fluids down.
  • Severe low blood sugar that causes a seizure, loss of consciousness, or inability to swallow safely.

What to be careful with

Give Fairview and your prescriber a complete list of everything you take.

Insulin and sulfonylureas can raise the risk of low blood sugar.

Mounjaro slows stomach emptying, which can affect oral medicines that need precise absorption or monitoring.

Birth-control pills may be less effective for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase. Use a non-oral method or add a barrier method during those windows.

Do not combine Mounjaro with another tirzepatide product or GLP-1 medicine unless the prescriber has planned the switch. Alcohol can worsen stomach symptoms and make glucose less predictable. Tell every anesthesia or procedure team about this medicine.

You do not need to memorize every interaction. Before you start, stop, or change another medicine or supplement, tell your pharmacist that you take Mounjaro. Every single time.

What it costs

The cost is different for every person, because every insurance plan is different.

Here is the honest way to find your price. If you pay cash, call Fairview and we will give you a price for your situation. If you have private insurance, there may be a coupon or a savings program from the maker of the drug that helps lower your cost, and we will check if one is available for you. The best step is to let a pharmacist look at your plan. We do this for every patient.

Do not let cost make you skip doses. Call us first. There is almost always something we can do.

Availability and insurance coverage can change. Fairview will check whether an FDA approved lower cost alternative, a manufacturer savings program, an insurance exception, or another cost saving option is available for your specific prescription.

What should be checked

Your monitoring plan depends on why you take the medicine, your dose, your other conditions, and your other medicines.

Your doctor should follow, now and then:

  • Home glucose and A1C, with readings reviewed more often if you use insulin or a sulfonylurea.
  • Kidney function if dehydration, vomiting, or diarrhea occurs.
  • Eye symptoms and recommended diabetic eye examinations.
  • Pancreatic, gallbladder, and severe stomach symptoms.

Your pharmacist should, now and then:

  • Check injection technique and adherence.
  • Confirm the reason for each dose increase against your prescription.
  • Check every new medicine and supplement against Mounjaro.
  • Help prevent refill gaps and ask about side effects.

At Fairview, we check for new medicines at every refill, ask about side effects, and reinforce correct use of your exact device.

Special situations

Before surgery or anesthesia.

Tell the team that you take Mounjaro, the form you use, and the last dose time. Follow their individualized fasting and medication directions. Do not hold or restart it on your own.

Pregnancy and pregnancy planning.

Tell the prescriber promptly. Poorly controlled diabetes also carries pregnancy risks, but animal data suggest fetal risk. Tirzepatide may reduce oral contraceptive effectiveness during initiation and dose escalation.

Breastfeeding.

Discuss the reason for treatment, the dosage form, available milk data, and the infant's needs with the prescriber.

If you cannot eat or drink.

Contact the care team, especially if you have diabetes or use insulin. Do not stop insulin on your own. Monitor glucose and ketones when your diabetes plan directs.

Travel.

Carry the labeled medicine and supplies with you. Protect from freezing and heat, and keep the weekly routine across time zones.

Storage and disposal.

Store Mounjaro in the original carton and do not freeze it. Single-dose pens and vials: refrigerate at 36 to 46 degrees F, or keep up to 86 degrees F for no more than 21 days. Multi-dose vials and single-patient-use KwikPens: refrigerate or keep up to 86 degrees F. Discard after a total of 30 days at room temperature, 30 days after first use, or 4 weekly doses, whichever limit is reached first. Dispose of needles, syringes, and single-dose devices in a sharps container.

How Fairview helps Mounjaro patients

When you fill Mounjaro at Fairview, here is what you get. This is normal care for us, not something extra.

At your first fill:

  • We confirm the medicine, strength, schedule, and treatment purpose.
  • We review interactions and explain the key safety rule.
  • We demonstrate your exact device when applicable.
  • We help build a workable weekly plan and identify insurance barriers.

At every refill:

  • We check for new medicines and ask about side effects.
  • We help prevent refill gaps and review laboratory or appointment needs.
  • We reinforce correct administration and look into cost changes.

When something changes:

  • We review any new medicine and contact the prescriber when needed.
  • We help you prepare medication information for surgery or travel.
  • We discuss side effects and counsel an approved caregiver.

Questions patients ask about Mounjaro

The weekly injection may be used with or without food.

Have a question about your Mounjaro? Ask a pharmacist who knows it well.

The key Mounjaro lesson is to use the exact product on the exact schedule, increase gradually, and speak up before procedures. Fairview can review your device routine, side effects, glucose or nutrition plan, other medicines, storage, and refill timing. Contact us for personalized counseling or for help filling or transferring the prescription.

Medical disclaimer. This guide is here to teach you. It is not medical advice, and it does not replace your doctor or pharmacist. Always do what your doctor tells you, and ask a pharmacist before you change how you take any medicine. Information about Mounjaro can change. This page was last reviewed on the date shown.

Written by Dr. Mike Acheampong, PharmD, MPH, a licensed Mississippi pharmacist.

Last reviewed: Clinically reviewed July 2026.

Sources: Reviewed against FDA Prescribing Information for Mounjaro (tirzepatide); manufacturer information.

CallTransferRefill